Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.
Read more
Artiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).
Read more
Artiria Medical raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing.
Read more
